{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:31:12Z","timestamp":1781803872248,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cgh.2016.12.038","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T02:02:00Z","timestamp":1484877720000},"page":"920-926.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Clinical Features, Response to Treatment, and Outcomes of\u00a0IgG4-Related Sclerosing Cholangitis"],"prefix":"10.1016","volume":"15","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-2671","authenticated-orcid":false,"given":"Susumu","family":"Tazuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuichi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.12.038_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00535-016-1163-7","article-title":"IgG4-related sclerosing cholangitis: all we need to know","volume":"51","author":"Zen","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12016-014-8430-2","article-title":"IgG4-associated cholangitis: a comprehensive review","volume":"48","author":"Hubers","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cgh.2016.12.038_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cgh.2016.12.038_bib4","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cgh.2016.12.038_bib5","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2016.12.038_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A\u00a0novel clinical entity, IgG4-related disease (IgG4RD): general concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cgh.2016.12.038_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.cgh.2016.12.038_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00535-012-0744-3","article-title":"Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system","volume":"48","author":"Okazaki","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.12.038_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A\u00a0new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPA.0b013e3181fab696","article-title":"Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria","volume":"40","author":"Kamisawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.cgh.2016.12.038_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/00365520701731263","article-title":"Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome","volume":"43","author":"Kamisawa","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.gie.2008.02.018","article-title":"A\u00a0new diagnostic endoscopic tool for autoimmune pancreatitis","volume":"68","author":"Kamisawa","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2016.12.038_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00535-006-1868-0","article-title":"Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal","volume":"41","author":"Okazaki","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan","volume":"41","author":"Kanno","year":"2012","journal-title":"Pancreas"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2016.12.038_bib16","first-page":"S487","article-title":"Sclerosing cholangitis associated with autoimmune pancreatitis","volume":"37","author":"Kawa","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2016.12.038_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1572-0241.2007.01040_8.x","article-title":"IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis","volume":"102","author":"Hamano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.12.038_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.12.038_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jhbp.50","article-title":"Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan","volume":"21","author":"Tanaka","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.cgh.2016.12.038_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","article-title":"Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012","volume":"19","author":"Ohara","year":"2012","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.cgh.2016.12.038_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.mpa.0000202941.85955.07","article-title":"Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography","volume":"32","author":"Nakazawa","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.cgh.2016.12.038_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification","volume":"47","author":"Nakazawa","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2016.12.038_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000440830","article-title":"IgG4-associated cholangitis: a mimic of PSC","volume":"33","author":"Beuers","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2016.12.038_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.28568","article-title":"Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies","volume":"64","author":"Doorenspleet","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.12.038_bib26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","article-title":"Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience","volume":"4","author":"Chari","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.12.038_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2011.05.019","article-title":"Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma","volume":"9","author":"Kalaitzakis","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.12.038_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jjco\/hyv088","article-title":"Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project","volume":"45","author":"Hori","year":"2015","journal-title":"Jpn J Clin Oncol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517300551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517300551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:54Z","timestamp":1761542514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517300551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1542356517300551"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.12.038","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Features, Response to Treatment, and Outcomes of\u00a0IgG4-Related Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}